Tango Therapeutics (TNGX) Current Assets (2020 - 2026)

Tango Therapeutics' Current Assets history runs 7 years deep, the most recent figure standing at $392.3 million for Q1 2026.

• On a quarterly basis, Current Assets rose 74.42% year-over-year to $392.3 million in Q1 2026; TTM through Mar 2026 was $392.3 million, a 74.42% increase from a year earlier, with the FY2025 full-year figure at $353.8 million, up 32.82% from the prior year.
• Current Assets advanced to $392.3 million in Q1 2026 per TNGX's latest filing, from $353.8 million in the prior quarter.
• Across five years, Current Assets topped out at $460.7 million in Q1 2022 and bottomed at $163.8 million in Q3 2025.
• The 5-year median for Current Assets is $346.5 million (2023), against an average of $331.0 million.
• Across the five-year window, Current Assets jumped 59288.42% in 2022 and slumped 45.55% in 2025, its largest moves.
• Year by year, Current Assets stood at $375.3 million in 2022, then fell by 7.66% to $346.5 million in 2023, then dropped by 23.14% to $266.3 million in 2024, then surged by 32.82% to $353.8 million in 2025, then advanced by 10.9% to $392.3 million in 2026.
• Per Business Quant, the three latest TNGX Current Assets figures stand at $392.3 million (Q1 2026), $353.8 million (Q4 2025), and $163.8 million (Q3 2025).